Related Experiment Videos

[Copper-binding proteins in liver, kidney and brain tissue from a Wilson's disease patient]

No to Shinkei = Brain and Nerve
|October 1, 1986
PubMed

Insights

Wilson's disease significantly increases copper-binding proteins (Cu-PBs) in liver and kidney tissues, primarily as copper-thionein (Cu-Th). Brain tissue shows elevated copper bound to novel proteins, indicating altered copper metabolism in Wilson's disease.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathology

Context:

  • Wilson's disease is a genetic disorder characterized by excessive copper accumulation in organs.
  • Copper toxicity profoundly affects liver, kidney, and brain function.
  • Understanding copper-binding proteins is crucial for diagnosing and treating Wilson's disease.

Purpose:

  • To investigate the distribution and forms of copper-binding proteins (Cu-PBs) in Wilson's disease patient tissues.
  • To quantify copper levels and identify specific Cu-PBs in liver, kidney, and brain.
  • To compare these findings with control tissues to elucidate disease-specific alterations.

Summary:

  • Copper levels were significantly elevated in the liver (28-fold), kidney (38-fold), and brain (3.5-fold) of a Wilson's disease patient compared to controls.
  • In Wilson's disease liver and kidney cytosols, increased copper was predominantly bound to copper-thionein (Cu-Th).
  • Wilson's disease brain cytosol showed elevated copper bound to two novel proteins (10 kDa and 20 kDa), distinct from control brain tissue.

Impact:

  • This study identifies specific copper-binding protein alterations in Wilson's disease, offering insights into disease mechanisms.
  • The findings highlight the differential roles of Cu-Th and novel proteins in copper dyshomeostasis.
  • Characterizing these proteins may lead to improved diagnostic markers and therapeutic targets for Wilson's disease.

Related Concept Videos